Lowdell Mark William

Track

Insider profile

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -35% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lowdell Mark William's trades of INmune Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
165.60
Quantity 48,113 +45.5%
Value US$3,653,548
Transaction date
Planned sale
Price
143.16
Quantity 13,592 -39.3%
Value US$1,161,519
Transaction date
Planned sale
Price
311.60
Quantity 3,382 +31.6%
Value US$3,242,957
Transaction date
Planned sale
Price
20.19
Quantity 24,150 -1.6%
Value US$487,588
Transaction date
Planned sale
Price
20.02
Quantity 5,850 -0.4%
Value US$117,117
Transaction date
Purchase
Price
6.23
Quantity 2,918 +0.2%
Value US$18,179
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-04 2021-11-03
PlS Planned sale
48,113 +45.5%
165.60
US$3,653,548 		48,113 +45.5% 165.60 US$3,653,548
2021-10-29 2021-10-27
PlS Planned sale
13,592 -39.3%
143.16
US$1,161,519 		13,592 -39.3% 143.16 US$1,161,519
2021-10-26 2021-10-22
PlS Planned sale
3,382 +31.6%
311.60
US$3,242,957 		3,382 +31.6% 311.60 US$3,242,957
2021-07-09 2021-07-08
PlS Planned sale
24,150 -1.6%
20.19
US$487,588 		24,150 -1.6% 20.19 US$487,588
2021-07-09 2021-07-07
PlS Planned sale
5,850 -0.4%
20.02
US$117,117 		5,850 -0.4% 20.02 US$117,117
2019-09-12 2019-09-11
B Purchase
2,918 +0.2%
6.23
US$18,179 		2,918 +0.2% 6.23 US$18,179